Hubei Jumpcan Pharmaceutical Co., Ltd. (600566.SS) SHH

Currency In CNY

AD

Valuation

Market Cap24.23B
Enterprise Value19.7B
P/E Ratio14.97
PEG Ratio1.69
Price/Sales Ratio4.59
Price/Book Ratio1.92
Enterprise/Revenue4.18
Enterprise/EBITDA11.24

Fiscal Year

Fiscal YearDecember 31, 2025
Most Recent QuarterSeptember 30, 2026

Profitability

Profit Margin0.31
Operating Margin0.34
AD

Management Effectiveness

Return On Assets0.11
Return On Equity0.13

Income Statement

Revenue6.22B
Revenue/Share6.46
Gross Profit4.91B
EBITDA2.48B
Net Income1.78B
Diluted EPS1.93

Balance Sheet

Total Cash11.76B
Total Cash/Share12.83
Total Debt1.44B
Total Debt/Equity0.1
Current Ratio4.88
Book Value Per Share15.39

Price History

52-Week Change6.54
52-Week High30.1
52-Week Low21.13
Moving Average 50 Days26.26
Moving Average 200 Days26.43

Statistics

Average Volume6.67M
Shares Outstanding922.15M
% Held by InstitutionsN/A

Dividend And Splits

Trailing Annual Dividend Rate1.74
Trailing Annual Dividend Yield5.9
Payout Ratio0.9
Last Split Factor13:10
Last Split DateMay 18, 2010
AD